Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -742 | 772 | -2,060 | -3,227 | -1,817 |
| Depreciation Amortization | 1,211 | 590 | 2,253 | 1,668 | 1,075 |
| Income taxes - deferred | 300 | N/A | N/A | N/A | N/A |
| Accounts receivable | -6,188 | -3,799 | 2,178 | 356 | -145 |
| Accounts payable and accrued liabilities | 2,915 | 1,117 | 183 | 897 | -805 |
| Other Working Capital | -396 | -3,029 | 465 | 2,576 | 388 |
| Other Operating Activity | 4,342 | 3,248 | -892 | -37 | 1,795 |
| Operating Cash Flow | $1,442 | $-1,101 | $2,127 | $2,233 | $491 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,092 | -875 | -2,840 | -2,404 | -1,404 |
| Investing Cash Flow | $-3,092 | $-875 | $-2,840 | $-2,404 | $-1,404 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 2,455 | 2,455 | 2,455 |
| Debt Repayment | -274 | -138 | -1,402 | -1,269 | -1,143 |
| Common Stock Issued | 1,407 | 1,387 | N/A | N/A | N/A |
| Dividend Paid | N/A | N/A | -14 | -14 | -7 |
| Other Financing Activity | -60 | -60 | 0 | 0 | 0 |
| Financing Cash Flow | $1,073 | $1,189 | $1,039 | $1,172 | $1,305 |
| Exchange Rate Effect | -43 | 26 | 126 | 111 | 78 |
| Beginning Cash Position | 21,446 | 21,446 | 20,994 | 20,994 | 20,994 |
| End Cash Position | 20,826 | 20,685 | 21,446 | 22,106 | 21,464 |
| Net Cash Flow | $-620 | $-761 | $452 | $1,112 | $470 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,442 | -1,101 | 2,127 | 2,233 | 491 |
| Capital Expenditure | -3,092 | -875 | -2,840 | -2,404 | -1,404 |
| Free Cash Flow | -1,650 | -1,976 | -713 | -171 | -913 |